Bank Of America Corp Taro Pharmaceutical Industries LTD Transaction History

Bank Of America Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.97 - $43.33 $202,186 - $213,833	-4,935 Reduced 53.85%	4,230 $179,000
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $25,855 - $33,382	789 Added 9.42%	9,165 $382,000
Q2 2023 Aug 14, 2023	BUY	$24.24 - $40.97 $166,528 - $281,463	6,870 Added 456.18%	8,376 $317,000
Q1 2023 May 12, 2023	BUY	$23.0 - $31.59 $19,343 - $26,567	841 Added 126.47%	1,506 $36,000
Q4 2022 Feb 10, 2023	SELL	$27.6 - $32.99 $5,464 - $6,532	-198 Reduced 22.94%	665 $19,000
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $747 - $1,037	-26 Reduced 2.92%	863 $26,000
Q2 2022 Aug 12, 2022	SELL	$35.0 - $43.59 $1,575 - $1,961	-45 Reduced 4.82%	889 $0
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $689 - $804	-16 Reduced 1.68%	934 $40,000
Q4 2021 Feb 08, 2022	BUY	$47.6 - $65.0 $9,615 - $13,130	202 Added 27.01%	950 $47,000
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $13,527 - $15,923	-217 Reduced 22.49%	748 $47,000
Q2 2021 Sep 13, 2021	BUY	$70.26 - $76.64 $67,800 - $73,957	965 New	965 $70,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.